Multiple myeloma: 2012 update on diagnosis, risk-stratification, and management

Rajkumar, S. Vincent·2012·American Journal of Hematology
DOI 10.1002/ajh.22237

Cited by (124)

Items 101–124 of 124

  1. Use of B-Cell Gene Rearrangement Studies to Establish Clonality in Non-producer Non-secretory Multiple Myeloma.
    Hadrian Mendoza, C. Tormey, A. Siddon · 2019 · Clinical Lymphoma, Myeloma & Leukemia
  2. Biology and Treatment of Skeletal Manifestations in Multiple Myeloma
    N. Stavropoulos, Argyro Papadoyiannis, D. Maltezas, Petros Z. Stavrou, G. Babis, P. Papagelopoulos, G. Pangalis, M. Kyrtsonis · 2014 · Journal of Cancer Therapy
  3. Toxicity of autologous hematopoietic cell transplantation in patients with multiple myeloma – comparison between two different induction regimens
    R. Ram, H. Magen-Nativ, L. Vidal, C. Herscovici, Anat Peck, P. Raanani, O. Shpilberg, M. Yeshurun · 2012 · Clinical Transplantation
  4. Multiple myeloma: treatment- related peripheral neuropathy.
    M. Dowling, Mary B. Kelly, Teresa Meenaghan · 2012 · British Journal of Nursing
  5. Attainment of a stringent complete response in multiple myeloma with thalidomide monotherapy.
    Nanae Aritaka, Kunimoto Ichikawa, Hiroko Nakamura, H. Yasuda, K. Ogura, Toshiharu Matsumoto, N. Komatsu, T. Hirano · 2012 · Internal medicine
  6. Acute Plasma Cell Leukemia Presenting as Primary Hyperammonemic Encephalopathy
    Dveet Patel, A. Mangano, D. Moccia, S. Esperti, Kunjan Udani, J. Henderson, N. Balanchivadze · 2020 · Journal of Medical Cases
  7. Hibridación in situ fluorescente (FISH) en el Instituto Nacional de Cancerología (INC) de Colombia. Experiencia de 5 años
    Tatiana Roncancio-Velandia, R. Parra-Medina, J. Mejía, Gonzalo Guevara Pardo · 2019 · Revista Colombiana de Cancerología
  8. 多发性骨髓瘤患者自体造血干细胞移植后长期随访的单中心结果
    W. Sui, D. Zou, Gang An, S. Yi, S. Deng, Wen-Yang Huang, Ting-Yu Wang, Jian Li, Hong Liu, Ming-Wei Fu et al. · 2017 · Chinese Journal of Hematology
  9. Study design for vulnerable older adults with multiple myeloma.
    N. Nathwani, T. Wildes · 2017 · Journal of Geriatric Oncology
  10. The effects of allogeneic stem cell transplantation with matched sibling donor versus autologous stem cell transplantation for newly diagnosed multiple myeloma
    Ya Tan, Shuang-Nian Xu, Xi Li, Jie-Ping Chen · 2016 · Cochrane Database of Systematic Reviews
  11. Multiple myeloma: Looking beyond standards
    E. Kaul, Sanjeevan Sharma · 2016 · Asian Journal of Oncology
  12. Life span and outcomes in patients with malignant neoplasms commencing renal replacement therapy (RRT) in the years 2001-2015 - one-centre experience
    G. Ostrowski, D. Daniewska, R. Gellert · 2015
  13. Frequency of the malignant neoplasms in population commencing renal replacement therapy (rrt) in the years 2001-2015 – one-unit experience
    G. Ostrowski, D. Daniewska, R. Gellert · 2015
  14. Bortezomib-Based Salvage Chemotherapy in Refractory/Relapsed Multiple Myeloma Patients: A Single Center Experience in Real Clinical Practice
    Dong Hyun Kim, Ji Hyun Lee, Sung Hyun Kim, S. Oh, Suee Lee, Sang-Yi Moon, Hyo-jin Kim · 2015
  15. Multiple myeloma – current status and future directions
    L. Rasche, S. Knop · 2013 · Expert Opinion on Orphan Drugs
  16. Is There an Optimal Timing of Autologous Stem-Cell Transplantation for Multiple Myeloma in the Era of Novel Agents?
    S. Toprak · 2013 · Turkish journal of haematology : official journal of Turkish Society of Haematology
  17. Promoting quality of life for patients with myeloma
    M. Dowling, Mary B. Kelly, Teresa Meenaghan · 2013 · Cancer Nursing Practice
  18. A classic presentation of an uncommon leukemia
    Kara N. Maxwell, David L. Porter · 2013 · American journal of hematology/oncology
  19. Induction Therapy in Multiple Myeloma
    Ş. Bakanay, M. Beksaç · 2013 · InTech eBooks
  20. Leczenie podtrzymujące w szpiczaku plazmocytowym
    S. Grosicki · 2013 · Acta Haematologica Polonica
  21. NOTCH PRODUCES A DEREGULATION OF CXCR4/SDF-1A CHEMOKINE SIGNALING IN MULTIPLE MYELOMA CELLS
    L. Apicella · 2013 · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano)
  22. Mieloma Múltiplp: importância dos fatores de PROGNÓSTICO NO TRATAMENTO
    S. V. Silva · 2012 · Open Repository of the University of Porto (University of Porto)
  23. Sustained response to single agent therapy with continuous lenalidomide in a pre-treated high-risk multiple myeloma patient
    E. Willenbacher, W. Willenbacher, Eberhard Gunsilius · 2012 · memo - Magazine of European Medical Oncology
  24. Plasma Cell Leukemia
    Nisha S. Joseph, A. Neppalli, A. Nooka · 2018 · Springer eBooks